AbbVie Inc (ABBV)
169.49
+1.60
(+0.95%)
USD |
NYSE |
Apr 23, 16:00
169.66
+0.17
(+0.10%)
After-Hours: 20:00
AbbVie Net Income (Annual): 4.863B for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.863B |
| December 31, 2022 | 11.84B |
| December 31, 2021 | 11.54B |
| December 31, 2020 | 4.616B |
| December 31, 2019 | 7.882B |
| December 31, 2018 | 5.687B |
| December 31, 2017 | 5.309B |
| December 31, 2016 | 5.953B |
| Date | Value |
|---|---|
| December 31, 2015 | 5.144B |
| December 31, 2014 | 1.774B |
| December 31, 2013 | 4.128B |
| December 31, 2012 | 5.275B |
| December 31, 2011 | 3.433B |
| December 31, 2010 | 4.178B |
| December 31, 2009 | 4.637B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
4.616B
Minimum
2020
11.84B
Maximum
2022
8.148B
Average
7.882B
Median
2019
Net Income (Annual) Benchmarks
| Amgen Inc | 6.717B |
| Immunogen Inc (DELISTED) | -222.93M |
| Johnson & Johnson | 35.15B |
| Eli Lilly and Co | 5.240B |
| Merck & Co Inc | 365.00M |